|
[1]Luth S, Herkel J, Kanzler S, et al.Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis[J].J Clin Gastroenterol, 2008, 42 (8) :926-930.
|
|
[2]Torres-Collado AX, Czaja AJ, Gelpi C.Anti-tRNP (ser) sec/SLA/LP autoantibodies.Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs[J].Liver Int, 2005, 25 (2) :410-419.
|
|
[3]Klein R, Berg PA.Significance of antibodies to soluble liver/liver pancreas antigen:experiences in Germany[J].Liver Int, 2010, 30 (1) :155-156.
|
|
[4]Czaja AJ, Donaldson PT, Lohse AW.Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis[J].Am J Gastroenterol, 2002, 97 (2) :413-419.
|
|
[5]Ma Y, Okamoto M, Thomas MG, et al.Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease[J].Hepatology, 2002, 35 (3) :658-664.
|
|
[6]Gueguen P, Dalekos G, Nousbaum JB, et al.Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1[J].J Clin Immunol, 2006, 26 (6) :495-505.
|
|
[7]Bridoux-Henno L, Maggiore G, Johanet C, et al.Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody[J].Clin Gastroenterol Hepatol, 2004, 2 (9) :825-830.
|
|
[8]Beland K, Lapierre P, Marceau G, et al.Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection[J].J Autoimmun, 2004, 22 (2) :159-166.
|
|
[9]Kakegawa T, Ise H, Sugihara N, et al.Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes[J].Cell Transplant, 2002, 11 (5) :407-415.J Clini Hepatol, March 2011, Vol.27, No.3
|
|
[10]Hausdorf G, Roggenbuck D, Feist E, et al.Autoanti-bodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis[J].Clin Chim Acta, 2009, 408 (1-2) :19-24.
|
|
[11]El-Din Elshazly LB, Youssef AM, Mahmoud NH, et al.Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children[J].Ital J Pediatr, 2009, 35 (1) :22.
|
|
[12]Czaja AJ, Shums Z, Norman GL.Nonstandard antibodies as prognostic markers in autoimmune hepatitis[J].Autoimmunity, 2004, 37 (3) :195-201.
|
|
[13]Montano-Loza A, Czaja AJ, Carpenter HA, et al.Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis[J].Autoimmunity, 2006, 39 (4) :341-348.
|
|
[14]Czaja AJ.Autoimmune liver disease[J].Curr Opin Gastroenterol, 2007, 23 (3) :255-262.
|
|
[15]Csepregi A, Nemesánszky E, Luettig B, et al.LKM3 autoantibodies in hepatitis C cirrhosis:a further phenomenon of the HCV-induced autoimmunity[J].Am J Gastroenterol, 2001, 96 (3) :910-911.
|
|
[16]Dalekos GN, Makri E, Loges S, et al.Increased inci-dence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece[J].Eur J Gastroenterol Hepatol, 2002, 14 (1) :35-42.
|
|
[17]Muratori P, Muratori L, Gershwin ME, et al.'True'an-timitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?[J].Clin Exp Immunol, 2004, 135 (1) :154-158.
|
|
[18]Shimoda S, Nakamura M, Ishibashi H, et al.Molecular mim-icry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis[J].Gastroenterology, 2003, 124 (7) :1915-1925.
|
|
[19]Bogdanos DP, Baum H, Butler P, et al.Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection[J].Dig Liver Dis, 2003, 35 (11) :801-805.
|
|
[20]Nakamura M, Kondo H, Mori T, et al.Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis[J].Hepatology, 2007, 45 (1) :118-127.
|
|
[21]Muratori P, Muratori L, Ferrari R, et al.Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis[J].Am J Gastroenterol, 2003, 98 (2) :431-437.
|
|
[22]周晔, 蒋天舒, 陈燕等.自身抗原gp210融合蛋白的重组表达及其临床应用研究[J].中华实验诊断学, 2007, 11 (6) :739-743.
|
|
[23]Yang WH, Yu JH, Nakajima A, et al.Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure[J].Clin Gastroenterol Hepatol, 2004, 2 (12) :1116-1122.
|
|
[24]Assassi S, Fritzler MJ, Arnett FC, et al.Primary biliary cirrhosis (PBC) , PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients[J].J Rheumatol, 2009, 36 (10) :2250-2256.
|
|
[25]Lüth S, Herkel J, Kanzler S, et al.Serologic markers compared with liver biopsy for monitoring disease activity in autoimmune hepatitis[J].J Clin Gastroenterol, 2008, 42 (8) :926-930.
|
DownLoad: